Bcal Diagnostics Ltd has released a press release.
Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- BCAL Early Cancer Detection Tests Update
- BCAL Establishes $10m Convertible Note Facility Revised
- BCAL Establishes $10 million Convertible Note Facility
- BCAL and ClearNote Partner on Early Cancer Detection Tests
- Appendix 4E and Annual Report
Later from BCAL Diagnostics
- Shareholder Update
- Half Yearly Report and Accounts
- BCAL Accelerates Rollout of Avantect Early Detection Tests
- BCAL Appoints Anne-Louise Arnett as Chief Executive Officer
- BCAL Launches Early Detection Cancer Platform
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics